Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
235,2 USD | +0,32% | +1,16% | +6,63% |
Omzet 2024 * | 2,7 mld. 2,52 mld. | Omzet 2025 * | 2,82 mld. 2,63 mld. | Marktkapitalisatie | 11,03 mld. 10,32 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,2 mld. 1,12 mld. | Nettowinst (verlies) 2025 * | 1,23 mld. 1,15 mld. | EV/omzet 2024 * | 2,86 x |
Nettoliquiditeiten 2024 * | 3,3 mld. 3,09 mld. | Nettoliquiditeiten 2025 * | 4,14 mld. 3,87 mld. | EV/omzet 2025 * | 2,45 x |
K/w-verhouding 2024 * |
9,79
x | K/w-verhouding 2025 * |
9,53
x | Werknemers | 1.168 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 62,77% |
Recentste transcriptie over United Therapeutics Corporation
1 dag | +0,32% | ||
1 week | +1,16% | ||
Lopende maand | +2,07% | ||
1 maand | -1,44% | ||
3 maanden | +7,66% | ||
6 maanden | +4,60% | ||
Lopend jaar | +6,63% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 69 | 26-06-96 | |
President | 52 | 01-04-11 | |
James Edgemond
DFI | Director of Finance/CFO | 56 | 01-01-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Raymond Kurzweil
BRD | Director/Board Member | 76 | 01-01-02 |
Chief Executive Officer | 69 | 26-06-96 | |
Tommy Thompson
BRD | Director/Board Member | 81 | 01-01-10 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
3.06% | 1 M€ | 0,00% | - | |
2.87% | 2 M€ | +5,19% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
23-04-24 | 234,5 | +0,18% | 521 396 |
22-04-24 | 234,1 | -1,63% | 552 493 |
19-04-24 | 237,9 | +0,42% | 616 033 |
18-04-24 | 236,9 | +0,69% | 476 359 |
17-04-24 | 235,3 | +1,52% | 372 437 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+6,63% | 11,03 mld. | |
+3,13% | 43,43 mld. | |
+48,66% | 41,69 mld. | |
+8,49% | 41,31 mld. | |
-10,82% | 27,14 mld. | |
+8,26% | 25,28 mld. | |
-23,69% | 18,47 mld. | |
+32,83% | 12,59 mld. | |
+1,58% | 12,33 mld. | |
-17,46% | 10,01 mld. |